ACER THERAPEUTICS INC

ACER NASDAQ

AngusMcK

ACER had a nice move overnight on the back of a few days of rallying. Still around 70% to get back to old highs so has some good wiggle room above current levels. Could be worth a look.

rwestbury

Bull Flag/Pennant

Bullishcharts

Potential breakout targets for ACER $6.00 to Historical monthly resistance level $7.25 to major pivot point $9.52 tp very strong Yearly Candle support Possible pennant breakout forming on increasing volume Golden Moving Average cross complete PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.

Bullishcharts

Alert set for break above $4.70 Nice up trending channel formed, with midpoint as current resistance. RSI and Volume bullish Golden cross complete PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.

itsilyasesmail

Looking for breakout of $4.5 resistance, measured move up to $7, previous breakout high.

AcornWealthCorp

Fallen Angel on Weekly chart. Like it as a long above 4.26. Stop signal 3.17. Momentum Target.

HorizontalPriceLevelsTrading

If you understand the idea, push a thumb up! Have a question? Don't be shy to ask!

TradeCobra

✌ You will want to play the breakout to the up or downside on the green triangle I have drawn.We are testing the top of a longterm downward Resistance. Daily Timeframe Crossover Strategy: Doji The EMA Dots: 3/3 Red Support Level: Bottom Green Triangle Resistance Level: Top Green Triangle Play the breakout and line up the indicators. Have an awesome day!...

Dinjin

Dates in the future with the greatest probability for a price high or price low. The Djinn Predictive Indicators are simple mathematical equations. Once an equation is given to Siri the algorithm provides the future price swing date. Djinn Indicators work on all charts, for any asset category and in all time frames. Occasionally a Djinn Predictive Indicator will...

TopMarketGainers

Investors eagerly await the FDA verdict on its NDA for Edviso, which is being evaluated for the treatment of vascular Ehlers -Danlos syndrome in patients with a confirmed type 111 collagen mutation. This for sure will be a market moving event. AVERAGE ANALYSTS PRICE TARGET $51.40 AVERAGE RECOMMENDATION BUY COMPANY PROFILE Acer Therapeutics, Inc. is a...

PennyStock101

Investors eagerly await the FDA verdict on its NDA for Edviso, which is being evaluated for the treatment of vascular Ehlers -Danlos syndrome in patients with a confirmed type 111 collagen mutation. This for sure will be a market moving event. AVERAGE ANALYSTS PRICE TARGET $51.40 AVERAGE RECOMMENDATION BUY COMPANY PROFILE Acer Therapeutics, Inc. is a...